High-dose cytosine arabinoside and daunorubicin postremission therapy in adults with de novo acute myeloid leukemia Long-term follow-up of a prospective multicenter trial

Gerhard Heil; P.S. Mitrou; D. Hoelzer; Mathias Freund; H. Link; G. Ehninger; B. Steinke; S. �hl; H. Wandt; E. Fackler-Schwalbe; Günter Schlimok; A. L�sch; W. Quei�er; B. L�ffler; Wilhelm Gaus; J. H�gel; H. Heimpel; E. Kurrle

doi:10.1007/s002770050110

JOURNAL ARTICLE

High-dose cytosine arabinoside and daunorubicin postremission therapy in adults with de novo acute myeloid leukemia Long-term follow-up of a prospective multicenter trial

Gerhard Heil P.S. Mitrou D. Hoelzer Mathias Freund H. Link G. Ehninger B. Steinke S. �hl H. Wandt E. Fackler-Schwalbe Günter Schlimok A. L�sch W. Quei�er B. L�ffler Wilhelm Gaus J. H�gel H. Heimpel E. Kurrle

Year: 1995 Journal: Annals of Hematology Vol: 71 (5)Pages: 219-225 Publisher: Springer Science+Business Media

DOI: 10.1007/s002770050110

Get Full-Text PDF Get Analytical Report

Keywords:

Medicine Daunorubicin Etoposide Internal medicine Cytarabine Gastroenterology Surgery Multicenter trial Prospective cohort study Hematology Chemotherapy Randomized controlled trial Multicenter study

Metrics

Cited By

0.00

FWCI (Field Weighted Citation Impact)

Refs

0.34

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Acute Myeloid Leukemia Research

Health Sciences → Medicine → Hematology

Multiple Myeloma Research and Treatments

Health Sciences → Medicine → Hematology

Histone Deacetylase Inhibitors Research

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

Related Documents

JOURNAL ARTICLE

High-dose cytosine arabinoside and daunorubicin postremission therapy in adults with de novo acute myeloid leukemia

Gerhard Heil Paris S. Mitrou D. Hoelzer Mathias Freund H. Link Gerhard Ehninger B. Steinke S. Öhl H. Wandt E. Fackler-Schwalbe G. Schlimok A Lösch W. Queißer B. Löffler W. Gaus Josef Högel H. Heimpel E. Kurrle

Journal: Annals of Hematology Year: 1995 Vol: 71 (5)Pages: 219-225

BOOK-CHAPTER

Long-term Follow Up of a Prospective Multicenter Trial with a High-Dose Cytosine Arabinoside and Daunorubicin Postremission Therapy in Adults with De Novo Acute Myeloid Leukemia

Gerhard Heil Paris S. Mitrou D. Hoelzer Mathias Freund H. Link Gerhard Ehninger B. Steinke S. Öhl H. Wandt E. Fackler-Schwalbe Günter Schlimok A Lösch W. Queißer B. Löffler Wilhelm Gaus Josef Högel H. Heimpel E. Kurrle

Hämatologie und Bluttransfusion Year: 1997 Pages: 824-830

JOURNAL ARTICLE

Consolidation Therapy with High-Dose Cytosine Arabinoside: Experiences of a Prospective Study in Acute Myeloid Leukemia

E. Kurrle Gerhard Ehninger E. Fackler-Schwalbe M. Freund Gerhard Heil D. Hoelzer Hartmut Link B. Löffler A Lösch P.S. Mitrou S. Öhl W. Queißer G. Schlimok H. Wandt

Journal: Hämatologie und Bluttransfusion Year: 1990 Vol: 33 Pages: 254-260

JOURNAL ARTICLE

Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia

Michael Flaßhove P. Meusers J. Schütte Richard Noppeney Dietrich W. Beelen Sebastian Sohrab Ulla Roggenbuck G. Kemmeries G. Brittinger S. Seeber M. E. Scheulen

Journal: Annals of Hematology Year: 2000 Vol: 79 (10)Pages: 533-542

BOOK-CHAPTER

Sequential Standard-Dose Cytosine Arabinoside/Mitoxantrone Therapy (SAM) in Adults with Acute Myeloid Leukemia

H. Radtke J. Schwamborn H. Daus D Hufnagl R. Herboth J. Preiß H.W. Pees

Hämatologie und Bluttransfusion Year: 1992 Pages: 421-424